Loading…

Binding and drug displacement study of colchicine and bovine serum albumin in presence of azithromycin using multispectroscopic techniques and molecular dynamic simulation

The binding and displacement interaction of colchicine and azithromycin to the model transport protein bovine serum albumin (BSA) was evaluated in this study. Azithromycin, a macrolide antibiotic, has antiviral properties and hence, has been used concomitantly with hydroxychloroquine against SARS-Co...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular liquids 2021-07, Vol.333, p.115934-115934, Article 115934
Main Authors: Wani, Tanveer A., Bakheit, Ahmed H., Al-Majed, Abdulrahman A., Altwaijry, Nojood, Baquaysh, Anwar, Aljuraisy, Ashwaq, Zargar, Seema
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The binding and displacement interaction of colchicine and azithromycin to the model transport protein bovine serum albumin (BSA) was evaluated in this study. Azithromycin, a macrolide antibiotic, has antiviral properties and hence, has been used concomitantly with hydroxychloroquine against SARS-CoV-2. Colchicine, a natural plant product is used to treat and prevent acute gout flares. Some macrolide antibiotics are reported to have fatal drug-drug interactions with colchicine. The displacement interaction between colchicine and azithromycin on binding to BSA was evaluated using spectroscopic techniques, molecular docking and molecular dynamic simulation studies. The binding constant recorded for the binary system BSA-colchicine was 7.44 × 104 whereas, the binding constant for the ternary system BSA-colchicine in presence of azithromycin was 7.38 × 104 and were similar. Azithromycin didn't bind to BSA neither did it interfere in binding of colchicine. The results from molecular docking studies also led to a similar conclusion that azithromycin didn't interfere in the binding of colchicine to BSA. These findings are important since there is possibility of serious adverse event with co-administration of colchicine and azithromycin in patients with underlying gouty arthritis and these patients need to be continuously monitored for colchicine toxicity. •Macrolide antibiotic are reported to have fatal drug-drug interaction with colchicine.•Plasma protein binding plays significant role in pharmacokinetics of drugs.•Spectroscopic, docking and MDS were used to study the in-vitro interaction.•Effect of azithromycin was investigated on colchicine-BSA interaction.•Displacement of colchicine from its binding site by azithromycin was evaluated.
ISSN:0167-7322
1873-3166
DOI:10.1016/j.molliq.2021.115934